| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 11. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | rituximab (Truxima®) |
| Formulation | 10 mg/ml concentrate for solution for infusion |
| Reference number | 3351 |
| Indication | Treatment of non-Hodgkin's follicular lymphoma (NHL), chronic lymphocytic leukaemia (CLL), rheuamatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis |
| Company | Celltrion Healthcare Co Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 16/12/2016 |